CompaniesAlar Pharmaceuticals
Alar Pharmaceuticals logo

Alar Pharmaceuticals

active
Taichung, Taiwan
Founded 2016
Website
About

505(b)(2) for CNS & Chronic Diseases

Areas of Focus

Categories

Taiwan
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

103

By Phase

PHASE1: 2

By Status

RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT04122755
Hover over trial bars to see details

Recent Trials

NCT06965569Lead Sponsor
Multiple Ascending Dose Phase 1 Study of ALA-3000
PHASE1Recruiting
44 participants
Started: Apr 21, 2025 · Completed: Oct 27, 2025
NCT04122755Lead Sponsor
Single Ascending Dose Study of ALA-1000
PHASE1Completed
59 participants
Started: Sep 16, 2019 · Completed: May 3, 2021
Locations (1)
Headquarters
Taichung, Taiwan
Map

Loading map...